Acropolis Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,265
| Closed | -$149K | – | 308 |
|
|
2024
Q3 | $149K | Sell |
2,265
-3
| -0.1% | -$198 | 0.01% | 259 |
|
|
2024
Q2 | $209K | Buy |
2,268
+3
| +0.1% | +$277 | 0.01% | 216 |
|
|
2024
Q1 | $216K | Sell |
2,265
-600
| -21% | -$57.3K | 0.01% | 214 |
|
|
2023
Q4 | $218K | Buy |
2,865
+1
| +0% | +$76 | 0.02% | 210 |
|
|
2023
Q3 | $198K | Sell |
2,864
-2
| -0.1% | -$139 | 0.02% | 214 |
|
|
2023
Q2 | $270K | Buy |
2,866
+1
| +0% | +$94 | 0.02% | 181 |
|
|
2023
Q1 | $237K | Hold |
2,865
| – | – | 0.02% | 186 |
|
|
2022
Q4 | $214K | Buy |
2,865
+5
| +0.2% | +$373 | 0.02% | 186 |
|
|
2022
Q3 | $236K | Hold |
2,860
| – | – | 0.02% | 171 |
|
|
2022
Q2 | $272K | Hold |
2,860
| – | – | 0.03% | 166 |
|
|
2022
Q1 | $337K | Hold |
2,860
| – | – | 0.03% | 147 |
|
|
2021
Q4 | $371K | Hold |
2,860
| – | – | 0.03% | 145 |
|
|
2021
Q3 | $323K | Hold |
2,860
| – | – | 0.04% | 147 |
|
|
2021
Q2 | $296K | Hold |
2,860
| – | – | 0.03% | 150 |
|
|
2021
Q1 | $239K | Buy |
2,860
+600
| +27% | +$50.1K | 0.02% | 159 |
|
|
2020
Q4 | $206K | Hold |
2,260
| – | – | 0.02% | 167 |
|
|
2020
Q3 | $180K | Buy |
+2,260
| New | +$180K | 0.02% | 164 |
|